Maria Dimou

1.9k total citations
51 papers, 396 citations indexed

About

Maria Dimou is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Maria Dimou has authored 51 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 18 papers in Hematology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Maria Dimou's work include Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (15 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Maria Dimou is often cited by papers focused on Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (15 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Maria Dimou collaborates with scholars based in Greece, United States and United Kingdom. Maria Dimou's co-authors include Panayiotis Panayiotidis, Marie‐Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Τατιάνα Τζένου, Gerassimos A. Pangalis, Nikolitsa Kafasi, Christina Kalpadakis, Efstathios Koulieris and Marina P. Siakantaris and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Maria Dimou

46 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Dimou Greece 11 182 153 146 113 95 51 396
Monica Tozzi Italy 8 139 0.8× 181 1.2× 77 0.5× 91 0.8× 139 1.5× 16 366
Massimo Pini Italy 10 112 0.6× 119 0.8× 80 0.5× 136 1.2× 128 1.3× 26 382
Sara Raponi Italy 15 225 1.2× 252 1.6× 108 0.7× 244 2.2× 215 2.3× 24 626
Simon Hallam United Kingdom 9 164 0.9× 52 0.3× 179 1.2× 161 1.4× 56 0.6× 23 400
Anna Sicuranza Italy 11 142 0.8× 71 0.5× 73 0.5× 94 0.8× 45 0.5× 40 295
Rama Al Hamed France 9 308 1.7× 56 0.4× 236 1.6× 223 2.0× 71 0.7× 11 487
Hajime Yasuda Japan 11 93 0.5× 115 0.8× 74 0.5× 111 1.0× 73 0.8× 55 366
Lynn Savoie Canada 11 298 1.6× 144 0.9× 238 1.6× 170 1.5× 97 1.0× 25 523
Amine Belhabri France 14 272 1.5× 112 0.7× 147 1.0× 95 0.8× 65 0.7× 40 458
Katarzyna Kapelko‐Słowik Poland 11 84 0.5× 45 0.3× 94 0.6× 78 0.7× 83 0.9× 25 336

Countries citing papers authored by Maria Dimou

Since Specialization
Citations

This map shows the geographic impact of Maria Dimou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Dimou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Dimou more than expected).

Fields of papers citing papers by Maria Dimou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Dimou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Dimou. The network helps show where Maria Dimou may publish in the future.

Co-authorship network of co-authors of Maria Dimou

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Dimou. A scholar is included among the top collaborators of Maria Dimou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Dimou. Maria Dimou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sachanas, Sotirios, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, et al.. (2025). GREEK CONSENSUS ON CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENT. Mediterranean Journal of Hematology and Infectious Diseases. 17(1). e2025014–e2025014.
3.
Diamantopoulos, Panagiotis, et al.. (2024). The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review. Advances in Hematology. 2024(1). 1370364–1370364. 1 indexed citations
4.
Dimou, Maria, Mohamed Abuzakouk, Mona Al‐Ahmad, et al.. (2024). Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East. SHILAP Revista de lepidopterología. 3. 1 indexed citations
5.
Dimou, Maria, Matthaios Speletas, Cinzia Milito, et al.. (2023). Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis. Cancers. 15(18). 4524–4524. 3 indexed citations
6.
Dimou, Maria, et al.. (2023). The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects. International Journal of Molecular Sciences. 24(18). 14110–14110. 2 indexed citations
7.
Diamantopoulos, Panagiotis, Georgios Dryllis, Marie‐Christine Kyrtsonis, et al.. (2023). The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia. PubMed. 5(2-3). 92–100. 2 indexed citations
8.
Borte, Michael, Leif G. Hanitsch, Nizar Mahlaoui, et al.. (2023). Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study. Journal of Clinical Immunology. 43(6). 1259–1271. 11 indexed citations
9.
Dimou, Maria, et al.. (2021). Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment. SHILAP Revista de lepidopterología. 9(7). e04514–e04514. 2 indexed citations
10.
Dimou, Maria, et al.. (2021). Pembrolizumab-induced Remission After Failure of Axicabtagene Ciloleucel: Case Report and Literature Review. In Vivo. 35(6). 3401–3406. 5 indexed citations
11.
Diamantopoulos, Panagiotis, Argiris Symeonidis, Ιoannis Kotsianidis, et al.. (2019). Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome. Annals of Hematology. 98(6). 1383–1392. 9 indexed citations
12.
13.
Sticht, Carsten, Markus Pfirrmann, Daniel Nowak, et al.. (2017). The EUROSKI biomarker study: Analyzing the mechanisms of treatment-free remission in chronic myeloid leukemia. Annals of Oncology. 28. v367–v367. 1 indexed citations
14.
Sotiropoulos, Damianos, Vasileios Papadopoulos, Maria Dimou, et al.. (2015). Ruxolitinib Efficacy and Safety in Myelofibrosis: A Multicenter Observational Study. Blood. 126(23). 5192–5192.
15.
Τζένου, Τατιάνα, et al.. (2015). Study of MGUS-Series: Disease Evolution, Coexistant Disorders and Other Clinical Observations. Blood. 126(23). 5323–5323. 1 indexed citations
16.
Kyrtsonis, Marie‐Christine, Efstathios Koulieris, Maria K. Angelopoulou, et al.. (2014). Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia. BioMed Research International. 2014. 1–5. 11 indexed citations
17.
Levidou, Georgia, Τατιάνα Τζένου, Marie‐Christine Kyrtsonis, et al.. (2013). The Role of CXC-Chemokine IL-8, IL-6 and CXCR2 Receptor in Lymphoplasmacytic Lymphoma: Correlations with Microvascular Characteristics and Clinical Features. 2(2). 110–118. 1 indexed citations
18.
Koulieris, Efstathios, Panayiotis Panayiotidis, Stephen J. Harding, et al.. (2012). Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma. Experimental Hematology and Oncology. 1(1). 9–9. 27 indexed citations
19.
Kyrtsonis, Marie‐Christine, Theodoros P. Vassilakopoulos, Nikolitsa Kafasi, et al.. (2007). Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma. British Journal of Haematology. 137(3). 240–243. 87 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Tozzi Breakdown of academic impact, for papers by Massimo Pini Breakdown of academic impact, for papers by Sara Raponi Breakdown of academic impact, for papers by Simon Hallam Breakdown of academic impact, for papers by Anna Sicuranza Breakdown of academic impact, for papers by Rama Al Hamed Breakdown of academic impact, for papers by Hajime Yasuda Breakdown of academic impact, for papers by Lynn Savoie Breakdown of academic impact, for papers by Amine Belhabri Breakdown of academic impact, for papers by Katarzyna Kapelko‐Słowik
Rankless by CCL
2026